RYR2 and colon adenocarcinoma: However, our study indicated that a single TP53 mutation does not affect survival, whereas the co-mutation of TP53 and other genes (such as RYR2, SYNE1, TTN, LRP18, and USH2A) significantly shortens the survival time of COAD patients.